Blocking the JNK pathway eased disease severity and extended survival in SMA mice, pointing to a potential new treatment ...

For columnist Sherry Toh, using the newest generation of technology allows for greater inclusion and accessibility in digital ...

Columnist Brianna Albers wasn't sure what to expect from her recent overnight sleep study, as she hadn't done one since 2002.

Evrysdi improved motor function and quality of life in children and adults with SMA, a real-world study in Hong Kong shows.

At 35, columnist Alyssa Silva is making the transition from pediatric to adult healthcare — a daunting change given the ...

Electrical signals called far-field potentials may help track disease progression in SMA, a new study suggests.

Sleep problems, common in SMA, may involve both nighttime breathing issues linked to muscle weakness and brain changes, per a ...

What do an unexpected job loss, a skunk, and a devastating diagnosis have in common? Columnist Helen Baldwin explains.

We are pleased to partner with the Muscular Dystrophy Association (MDA) to bring you coverage from the MDA Clinical & Scientific Conference.

Spinal muscular atrophy (SMA) is an inherited neurodegenerative disorder characterized by progressive muscle weakness. SMA patients do not produce enough of a protein called survival motor neuron (SMN ...

Children with spinal muscular atrophy (SMA) given the gene therapy Zolgensma (onasemnogene abeparvovec-xioi) in infancy are maintaining motor milestones after up to a decade of follow-up, according to ...

Novartis has completed negotiations with the pan-Canadian Pharmaceutical Alliance (pCPA) regarding pricing and availability of Zolgensma (onasemnogene abeparvovec), its approved gene therapy for ...